CR Bard fundamentals

Use CR Bard Inc fundamentals together with your stock portfolios to protect against small markets fluctuations and to determine Stock optimization strategy that fits your criteria.  Suggest Portfolio

CR Bard Inc is rated second in operating margin category among related companies. It is rated below average in book value per share category among related companies creating about  0.89  of Book Value Per Share per Operating Margin. The ratio of Operating Margin to Book Value Per Share for CR Bard Inc is roughly  1.12 

Operating Margin ( % )

Return On Equity Return On Asset Profit Margin Operating Margin Current Valuation Shares Outstanding Shares Owned by Insiders Shares Owned by Institutions Number of Shares Shorted Price to Earning Price to Book Price to Sales Revenue Gross Profit EBITDA Net Income Cash and Equivalents Cash per Share Total Debt Debt to Equity Current Ratio Book Value Per Share Cash Flow from Operations Short Ratio One Year High One Year Low Earnings Per Share Price to Earnings To Growth Number of Employees Beta Market Capitalization Total Asset Retained Earnings Working Capital Current Asset Current Liabilities Z Score Probability Of Bankruptcy

CR Bard competes with BAXTER, COVIDIEN, BECTON, DENTSPLY, and CareFusion. CR Bard Inc offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusions catheters, guidewires, fabrics, meshes, introducers, and accessories; peripheral vascular stents, covered stents, and vascular grafts; vena cava filters; biopsy devices; electrophysiology products; and drug coated balloon devices to treat peripheral vascular disease and heart arrhythmias. Its urology solutions comprise Foley catheters to reduce the rate of urinary tract infections; surgical slings to treat stress urinary incontinence; fecal incontinence products; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal; catheter stabilization devices; and solutions for therapeutic hypothermia. CR Bard Inc also offer oncology products, such as specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Its surgical specialty solutions include soft tissue repair products, such as hernia repair grafts and hernia fixation devices; surgical sealants for intraoperative sealing of air leaks in thoracic surgery; and other products, such as irrigation, wound drainage, and original equipment manufacturers? products. CR Bard Inc sells its solutions to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities directly, as well as through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.